Comparing Dual Mini-fragment Plating to Single Precontoured Plating of Acute Midshaft Clavicle Fractures Trial

NCT ID: NCT05231343

Last Updated: 2023-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-04

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rate of surgical fixation of fractures of the collarbone (i.e., midshaft clavicle) has exponentially increased in recent years; however, the rate of repeat procedures for removal of these implants (i.e., plates) due to irritation remains high. Despite technological advances in implant design, nearly one in four patients with a surgically fixed collarbone ultimately undergoes removal of their implant. More recently, there has been a growing body of literature demonstrating the effectiveness of using two smaller caliber plates, which have been found to have similar rates of implant removal. As such, the proposed randomized clinical trial seeks to be the first level I study to directly compare dual mini-fragment plating of acute displaced midshaft clavicle fractures to single precontoured plating. The investigators hypothesize that dual mini-fragment plating will result in lower rates of reoperation with similar rates of union and complication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Midshaft clavicle fractures have traditionally been treated non-operatively with immobilization in a sling or a figure-of-eight bandage. Early studies reported a non-union rate of 1% and negligible functional consequence with conservative management. However, the inclusion of pediatric fractures and an absence of modern functional assessments in these studies resulted in an underestimation of non-union rates and overly optimistic clinical outcomes. More recent data has demonstrated a non-union rate of 15% with approximately 30% of patients dissatisfied with their outcome following non-operative treatment. As a result, there has been renewed interest in surgical fixation of displaced midshaft clavicle fractures. In fact, the rate of operative fixation has exponentially increased following the publication of a landmark randomized controlled trial by the Canadian Orthopaedic Trauma Society (COTS) which was the first of many level I studies to demonstrate higher union rates, decreased rates of symptomatic malunion, earlier return to function, and improved patient-reported outcomes with plate fixation of displaced midshaft clavicle fractures.

Traditional plating techniques for open reduction and internal fixation of clavicle fractures involved the use of a single 3.5-mm plates placed superiorly or anteriorly. However, these plates are often very prominent under the skin causing irritation, and in many cases result in reoperation for hardware removal. The rate of reoperation for removal of symptomatic hardware has been reported to range from 8% to 66%. For this reason, there have been a number of different fixation strategies describes to minimize the need to return to the operating room for implant-related symptoms. These include intramedullary nailing and the use of anatomic precontoured clavicle plates positioned superiorly or anteroinferiorly. However, even with the use of precontoured plates, the reported hardware removal rate varies from 5% to 47%. This is likely due to the significant variation in clavicle anatomy (i.e., sigmoid curve, coronal bow and length) observed between individuals which precludes anatomic fitting of precontoured plates in all patients. In fact, Malhas and colleagues published a cadaveric study that found further contouring of precontoured plates was necessary in 73% of cases to optimize plate-bone fit.

More recently, a dual plate construct using two mini-fragment plates (i.e., 2.4-mm or 2.7-mm plates) placed orthogonally has been advocated as a means of decreasing the rate of reoperation for symptomatic hardware removal. In 2015, Prasarn et al. reported on a series of 17 patients undergoing clavicle fixation using a 2.7-mm plate positioned superiorly and a 2.4-mm plate positioned anteriorly and had no reoperations while noting a 100% union rate. The idea of dual plating is not new and is commonly used in the setting of clavicle fracture non-union fixation. Its efficacy has also been described in distal clavicle fractures. Dual plating may serve as the ideal low-profile implant option to help diminish the high rates of symptomatic implant removal observed with single plating. The benefits associated with a dual plate construct extend beyond a reduction in implant-related soft-tissue irritation. Intraoperatively, dual plating allows for more points of fixation, buttressing of anterior butterfly fragments, mini-fragment plates to be used as washers for multiple lag screws, and the use of either the superior or anterior plate as a reduction aid or clamp, while the second plate is applied. Based on existing biomechanical data in the literature, the ability of a dual plate construct to withstand multiplanar bending forces better than a single plate construct may also allow for early weight-bearing through the affected extremity. Despite the aforementioned benefits of dual plate fixation, there remains a lack of level I evidence for its use in the surgical management of acute midshaft clavicle fractures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clavicle Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual mini-fragment plating

Group Type EXPERIMENTAL

Dual Mini-fragment Plating

Intervention Type PROCEDURE

Patients randomized to dual mini-fragment plating will undergo clavicle fixation using any configuration of 2.0-mm, 2.4-mm and 2.7-mm limited contact dynamic compression (LC-DCP), locking compression (LCP) or reconstruction plates (i.e., 2.4-mm superior and 2.7-mm anteroinferior). One of the two plates used must be a LC-DCP or LCP plate. Surgeons will contour the mini-fragment plate intraoperatively to fit each patient's anatomy.

Single precontoured plating

Group Type ACTIVE_COMPARATOR

Single Precontoured Plating

Intervention Type PROCEDURE

Patients randomized to a single plate construct will undergo fixation using an anatomically precontoured (superior or anterior-inferior) clavicle plate.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dual Mini-fragment Plating

Patients randomized to dual mini-fragment plating will undergo clavicle fixation using any configuration of 2.0-mm, 2.4-mm and 2.7-mm limited contact dynamic compression (LC-DCP), locking compression (LCP) or reconstruction plates (i.e., 2.4-mm superior and 2.7-mm anteroinferior). One of the two plates used must be a LC-DCP or LCP plate. Surgeons will contour the mini-fragment plate intraoperatively to fit each patient's anatomy.

Intervention Type PROCEDURE

Single Precontoured Plating

Patients randomized to a single plate construct will undergo fixation using an anatomically precontoured (superior or anterior-inferior) clavicle plate.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18 and 65 years of age
* A completely displaced midshaft fracture of the clavicle (no cortical contact between the main proximal and distal fragments (AO/OTA 15.2A/B/C)
* Fracture amenable to plate fixation with a minimum of three screws in each proximal and distal fragment

Exclusion Criteria

* Open fracture
* Pathological fracture
* Fracture seen \> 28 days after injury
* Associated neurovascular injury
* Associated head injury (Glasgow Coma Scale \< 12)
* Concomitant ipsilateral upper extremity fracture
* Significant medical comorbidities (i.e., ASA grade IV and V)
* Inability to comply with follow-up and
* Lack of consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Orthopaedic Trauma Society

OTHER

Sponsor Role collaborator

Sunnybrook Health Sciences Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Ujash Sheth

Orthopaedic Surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ujash Sheth, MD MSc FRCSC

Role: PRINCIPAL_INVESTIGATOR

Sunnybrook Health Sciences Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara Aman, BSc

Role: CONTACT

416-480-4285

Katrine Milner, BSc

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alicia Alvares, BSc

Role: primary

416-480-4285

Katrine Milner, BSc

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COMPACT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.